Pharming Group is engaged in the development of products for the treatment of unmet medical needs. Pharming Group is engaged in the development of products for the treatment of unmet medical needs.
Pharming Group to participate in September investor conferences PR Newswire LEIDEN, The Netherlands, Aug. 24, 2023 LEIDEN, The Netherlands, Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V...
Pharming Group to convene Extraordinary General Meeting of Shareholders PR Newswire LEIDEN, The Netherlands, Aug. 14, 2023 LEIDEN, The Netherlands, Aug. 14, 2023 /PRNewswire/ -- Pharming Group...
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan PR Newswire LEIDEN, The Netherlands, Aug. 9, 2023 Single-arm Phase III study...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約